[HTML][HTML] Soluble ACE2 as a potential therapy for COVID-19
S Krishnamurthy, RF Lockey… - American Journal of …, 2021 - journals.physiology.org
Soluble angiotensin-converting enzyme 2 (sACE2) could be a therapeutic option to treat
coronavirus disease 2019 (COVID-19) infection. Severe acute respiratory syndrome …
coronavirus disease 2019 (COVID-19) infection. Severe acute respiratory syndrome …
ACE2 Shedding and the Role in COVID-19
J Wang, H Zhao, Y An - Frontiers in Cellular and Infection …, 2022 - frontiersin.org
Angiotensin converting enzyme 2 (ACE2), a transmembrane glycoprotein, is an important
part of the renin-angiotensin system (RAS). In the COVID-19 epidemic, it was found to be the …
part of the renin-angiotensin system (RAS). In the COVID-19 epidemic, it was found to be the …
[HTML][HTML] Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
ACE2 is the indispensable entry receptor for SARS-CoV and SARS-CoV-2. Because of the
COVID-19 pandemic, it has become one of the most therapeutically targeted human …
COVID-19 pandemic, it has become one of the most therapeutically targeted human …
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
A recent study by Zoufaly et al. published in The Lancet Respiratory Medicine describes
encouraging data from the first severe COVID-19 patient successfully treated with human …
encouraging data from the first severe COVID-19 patient successfully treated with human …
ACE2 as a therapeutic target for COVID-19; its role in infectious processes and regulation by modulators of the RAAS system
V Michaud, M Deodhar, M Arwood… - Journal of Clinical …, 2020 - mdpi.com
Angiotensin converting enzyme 2 (ACE2) is the recognized host cell receptor responsible for
mediating infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
mediating infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Targeting ACE2 for COVID-19 therapy: opportunities and challenges
The coronavirus disease (COVID-19) pandemic is sweeping the globe. Even with a number
of effective vaccines being approved and available to the public, new cases and escalating …
of effective vaccines being approved and available to the public, new cases and escalating …
[HTML][HTML] Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
J Bian, Z Li - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) outbreak is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme 2 …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme 2 …
Interaction of SARS-CoV-2 and other coronavirus with ACE (angiotensin-converting enzyme)-2 as their main receptor: therapeutic implications
AM Davidson, J Wysocki, D Batlle - Hypertension, 2020 - Am Heart Assoc
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 originated from Wuhan,
China, in December 2019 and rapidly spread to other areas worldwide. Since then …
China, in December 2019 and rapidly spread to other areas worldwide. Since then …
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
The recent emergence of coronavirus disease-2019 (COVID-19) as a global pandemic has
prompted scientists to address an urgent need for defining mechanisms of disease …
prompted scientists to address an urgent need for defining mechanisms of disease …
Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2
ACE2 (angiotensin-converting enzyme 2) has a multiplicity of physiological roles that
revolve around its trivalent function: a negative regulator of the renin-angiotensin system …
revolve around its trivalent function: a negative regulator of the renin-angiotensin system …